• 제목/요약/키워드: Biological therapy

검색결과 765건 처리시간 0.024초

우울증 치료에 있어서 약물의 Combination과 Augmentation 전략 (Combination & Augmentation Strategies in the Treatment of Depressive Disorder)

  • 김형섭
    • 생물정신의학
    • /
    • 제7권2호
    • /
    • pp.131-139
    • /
    • 2000
  • Even the pharmacotherapy is more effective than placebo for the treatment of depression, the outcome of pharmacoltherapy remains unsatisfactory for many patients. Apart from side effects, there are two major limitations of antidepressant therapy. One is the delayed onset of improvement and another is partial response. In order to address these clinical dilemmas, many psychiatrists more commonly employ add-on therapy. In past, the practice of using multiple drugs to enhance treatment response was called polypharamcy, and was disparaged as poor clinical practice. However, with improved understanding of how drugs affects the central nervous system and increased communication in journals and on computer networks about the relative merits of specific combinations, the scientific basis for the combining drugs is being defined. Indeed, the use of multiple medications as a stratege to enhance response has become both acceptable and widespread now a days. It is now referred to more positively as add-on therapy, co-medication, combination therapy, or drug augmentation. Thus, as the methods of practical strategies for treatment of depression, switching classes antidepressant drugs, combination therapy, augmentation strategies and brief treatment algorithm will be presented with items of considerations. However, when combination of drugs being tried, knowledges about the action of mechanism, pharamcokinetics, and pharmacodynamics are essential to cope with the possible adversive reactions and to get the appropriate responses for the treatment of depressive symptoms.

  • PDF

복합부위통증증후군의 작업치료적 접근에 관한 고찰 (A Review of Occupational Therapy Approach for Complex Regional Pain Syndrome)

  • 최유임;박수현
    • 한국콘텐츠학회논문지
    • /
    • 제10권1호
    • /
    • pp.286-294
    • /
    • 2010
  • 복합부위통증증후군은 외상, 신경 손상, 골절, 뇌졸중, 척수 손상과 수술 등에 의해 부적합하게 발생하는 만성 신경병성 통증증후군으로, 질환의 경과, 치료법 등 모든 면에서 생물심리사회적 요인의 영향을 받는다. 작업치료에서는 생물학적, 심리적, 사회적 요소를 고려한 다학제적인 치료적 접근이 유용할 것이다. 생물학적 치료는 모든 영역에서의 독립성을 향상시키기 위해 사지의 기능적 사용을 증가시키는 것이다. 심리적 치료는 이완/바이오피드백 훈련과 인지행동치료를 제공하고, 사회적 치료는 레크리에이션 치료와 직업 재활을 실시할 수 있다. 복합부위통증증후군에 대한 작업치료는 다양한 전문 분야의 협조적인 치료과정을 통해 기능 회복과 통증 관리, 심리적 요인들의 회복을 이끌어 내야 할 것이다.

성인 환자의 산림치유 프로그램에 대한 체계적 문헌 고찰 (Systematic Review of Forest Therapy Program for Adult Patients with Diseases)

  • 채영란;이선희
    • Journal of Korean Biological Nursing Science
    • /
    • 제22권3호
    • /
    • pp.157-171
    • /
    • 2020
  • Purpose: The purpose of this study was to analyze the characteristics and effects of the forest therapy programs for adult patients. Methods: Six databases (PubMed, Cochrane library, CiNii, PsychoInFO, AGRICOL, EMBASE) and six domestic databases were systematically searched with language restrictions of Korean, English, and Japanese. The systematic review was based on the Preferred Reporting Items Systematic Reviews and Meta-Analysis (PRISMA) flow diagram. Results: Twenty five studies met the inclusion criteria. A systematic review identified adult patients classified as 1) disease of the circulatory system, 2) mental and behavioral disorders, 3) malignant neoplasms, 4) etc. (diabetes mellitus, chronic pain). This integrative review showed a positive effect of the forest therapy program for adult patients on physiological indices such as blood pressure, heart rate, heart rate variability, level of stress hormone, and natural killer cells as well as social·psychological indices such as the Profile of Mood States (POMS), anxiety, depression, and quality of life. Conclusion: The results of this study could be useful key principles in developing and applying the forest therapy programs in nursing intervention. Further research should be conducted to develop the forest therapy programs suitable for each patient group and measure its effectiveness.

Factors that Affect Remission of Chemotherapy-Induced Peripheral Neuropathy Symptoms: Short-Term Prospective Study

  • Jeong, Gay Suk;Choi, Jin Yi;Choi, Heejung
    • Journal of Korean Biological Nursing Science
    • /
    • 제24권2호
    • /
    • pp.86-94
    • /
    • 2022
  • Purpose: Patients experiencing chemotherapy-induced peripheral neuropathy (CIPN) apply various palliative care as well as drugs in their daily life to alleviate symptoms. There is a need to identify the influence of these efforts and patients' psychosocial status on the relief of CIPN symptoms. This short-term prospective study investigated how prescription drugs, non-pharmacological behaviors (exercise, massage, and heat therapy), and psychological states (social support, depression, and anxiety) affected CIPN symptoms. Methods: Participants scheduled to receive postoperative platinum or taxane-based chemotherapy were enrolled consecutively. CIPN was measured with the Neurotoxicity-12 subscale of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity-12 instrument. Data were collected three times during the 4 or 5 cycles of chemotherapy. Results: At the end of the 2nd chemotherapy cycle, 93.1% of participants reported CIPN symptoms. Multiple regression analyses showed that a heat therapy (β= -.34, p< .001), massage (β= -.21, p= .012), and walking 5 times or more per week (β= -.26, p= .021) provided relieve for CIPN symptoms. Depression (β= .19, p= .027) significantly exacerbated CIPN symptoms. Conclusion: These results suggested that a comprehensive management program that includes walking, heat therapy, massage, and mood therapy should be encouraged. Moreover, patients should be educated at chemotherapy initiation to understand appropriate interventions that can relieve CIPN symptoms.

A Sphingosine Kinase-1 Inhibitor, SKI-II, Induces Growth Inhibition and Apoptosis in Human Gastric Cancer Cells

  • Li, Pei-Hua;Wu, Jin-Xia;Zheng, Jun-Nian;Pei, Dong-Sheng
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권23호
    • /
    • pp.10381-10385
    • /
    • 2015
  • SKI-II has been reported as an inhibitor of sphingosine kinase 1 and has been extensively used to prove the involvement of sphingosine kinase and sphingosine-1-phosphate (Sphk1) in cellular processes. In the current study, we investigated the effects of SKI-II and its potential mechanisms in human gastric cancer SGC7901 cells. After treatment with SKI-II, cell growth, cell cycle distribution, apoptosis, expression of Sphk1, NF-${\kappa}B$, Bcl-2, Bax and p27 were assessed by MTT assay, flow cytometry, electron microscopy, immunocytochemistry and Western-blot assay, respectively. Our results showed that SKI-II markedly inhibited SGC7901 cell survival in a dose-dependent manner, reduced cell proliferation with accumulation of cells in the G0/G1 phase and induced apoptosis in the tumor cells. Furthermore, Western blotting and immunocytochemistry showed that the expression of p27 and Bax was increased significantly, but the expression of NF-${\kappa}B$, Bcl-2 and Sphk1 decreased by different degrees. These results indicate that SKI-II induced cell growth arrest and apoptosis. The increased apoptotic sensitivity of SGC7901 was correlated with NF-${\kappa}B$ or Bcl-2/Bax activation.

SETDB1 mediated FosB expression increases the cell proliferation rate during anticancer drug therapy

  • Na, Han-Heom;Noh, Hee-Jung;Cheong, Hyang-Min;Kang, Yoonsung;Kim, Keun-Cheol
    • BMB Reports
    • /
    • 제49권4호
    • /
    • pp.238-243
    • /
    • 2016
  • The efficacy of anticancer drugs depends on a variety of signaling pathways, which can be positively or negatively regulated. In this study, we show that SETDB1 HMTase is down-regulated at the transcriptional level by several anticancer drugs, due to its inherent instability. Using RNA sequence analysis, we identified FosB as being regulated by SETDB1 during anticancer drug therapy. FosB expression was increased by treatment with doxorubicin, taxol and siSETDB1. Moreover, FosB was associated with an increased rate of proliferation. Combinatory transfection of siFosB and siSETDB1 was slightly increased compared to transfection of siFosB. Furthermore, FosB was regulated by multiple kinase pathways. ChIP analysis showed that SETDB1 and H3K9me3 interact with a specific region of the FosB promoter. These results suggest that SETDB1-mediated FosB expression is a common molecular phenomenon, and might be a novel pathway responsible for the increase in cell proliferation that frequently occurs during anticancer drug therapy.

Characterization of Phage-Resistant Strains Derived from Pseudomonas tolaasii 6264, which Causes Brown Blotch Disease

  • Yun, Yeong-Bae;Han, Ji-Hye;Kim, Young-Kee
    • Journal of Microbiology and Biotechnology
    • /
    • 제28권12호
    • /
    • pp.2064-2070
    • /
    • 2018
  • Pseudomonas tolaasii 6264 is a representative strain that causes bacterial blotch disease on the cultivated oyster mushroom, Pleurotus ostreatus. Bacteriophages are able to sterilize the pathogenic P. tolaasii strains, and therefore, they can be applied in creating disease-free mushroom cultivation farms, through a method known as "phage therapy". For successful phage therapy, the characterization of phage-resistant strains is necessary, since they are frequently induced from the original pathogenic bacteria in the presence of phages. When 10 different phages were incubated with P. tolaasii 6264, their corresponding phage-resistant strains were obtained. In this study, changes in pathogenic, genetic, and biochemical characteristics as well as the acquired phage resistance of these strains were investigated. In the phylogenetic analyses, all phage-resistant strains were identical to the original parent strain based on the sequence comparison of 16S rRNA genes. When various phage-resistant strains were examined by three different methods, pitting test, white line test, and hemolytic activity, they were divided into three groups: strains showing all positive results in three tests, two positive in the first two tests, and all negative. Nevertheless, all phage-resistant strains showed that their pathogenic activities were reduced or completely lost.

주요우울장애에서의 전기경련요법 (Electroconvulsive Therapy in Major Depressive Disorder)

  • 이화영;강이헌;이민수
    • 생물정신의학
    • /
    • 제15권2호
    • /
    • pp.75-82
    • /
    • 2008
  • Major depressive disorder(MDD) is one of the most common diseases with serious health consequences such as increased morbidity, disability, and mortality. Electroconvulsive therapy(ECT) has been used as a treatment for mental disorder since the 1930s. A growing number of recent publications support the conclusions that ECT is an effective and safe treatment for depressed patients. Dosing strategies, frequency, safety, side effects and efficacy of ECT in MDD will be considered. ECT may be an alternative to treatment with antidepressants.

  • PDF

초음파가 생쥐의 혈소판에 미치는 영향 (The effects of Ultrasound on the Platelet of Rats)

  • 조광호;박상옥;박래준
    • The Journal of Korean Physical Therapy
    • /
    • 제13권1호
    • /
    • pp.139-149
    • /
    • 2001
  • We found out that there exists threshold dose for the decreased platelet count when we apply change of the platelet count to the defense of the ultrasound experiment. Those diminution is definite effects from the defense of the ultrasound. The number of the platelet count is decreased when we are exposed to ultrasound simultaneously. This should not be occurred. It is easy to use the number of the platelet count in the measurement of the biological dosage and intensity in high dosage relatively due to definite quantative relationship. The biological index to understand synergic effects. which are present when two harmful environmental factors are operating at the same time is functionally assending and antagonistic. There are scattered many factors as physical, Chemical, or physiochemically elements which are harmful to human body in the environment in consideration of ultrasound and the other factors. This experiment is demonstrating that we can use the change of the platelet as an index representing synergic effects of ultrasound.

  • PDF

전기경련치료에 대한 사회적 낙인과 해소 방안 (Social Stigmata of Electroconvulsive Therapy and Their Reduction Strategies)

  • 이준희;김민아;김세현;이유상;권준수
    • 생물정신의학
    • /
    • 제27권2호
    • /
    • pp.37-41
    • /
    • 2020
  • Modified electroconvulsive therapy (ECT) which started in 1950s is a safe and efficacious treatment for several mental disorders including mood disorders and psychotic disorders. However, its usage in present days is still limited by misconceptions and stigmata of ECT. This paper overviews the background from which the stigmata of ECT stemmed and the current status of stigmata surrounding ECT among the public and medical professionals. In addition, a few potential strategies for reducing stigmata of ECT are provided in this review.